Ali Y. Suliman, MD, MSc

Assistant Member, St. Jude Faculty

Departments

Department of Bone Marrow Transplantation & Cellular Therapy

Education

MD - University of Khartoum, Khartoum, Sudan
MSc - Georgetown University, Washington DC
Residency - University Iowa Hospital and Clinics, Iowa City, Iowa
Fellowship - Yale University School of Medicine, New Haven, Connecticut
Fellowship - Bone Marrow Transplant, St. Jude Children’s Research Hospital, Memphis, Tennessee

Research Interests

Long-term complication of transplant
Optimal CD34+ cell dose from bone marrow graft
T-Cell immune reconstitution and anti-viral antibodies

Contact Information

Ali Y. Suliman, MD, MSc Bone Marrow Transplantation & Cellular Therapy MS 1130, Room I3342 St. Jude Children's Research Hospital 262 Danny Thomas Place Memphis, TN 38105-3678

Email: ali.suliman@stjude.org
Phone: (901) 595-2740

St. Jude Faculty List

Selected Publications

Castejon-Ramirez S, Chaisavaneeyakorn S, Ferrolino JA, Allison KJ, Peterson M, Dallas RH, Suliman A, Hayden RT, Maron G, Hijano DR. Clinical outcomes of human rhinovirus/enterovirus infection in pediatric hemopoietic cell transplant patients. J Pediatric Infect Dis Soc Jan 29;13(1):75-83, 2024.

Pfeiffer T, Li Y, Ashcraft E, Karol SE, Rubnitz JE, Epperly R, Madden R, Mamcarz E, Obeng E, Qudeimat A, Sharma A, Srinivasan A, Suliman A, Talleur AC, Velasquez MP, Gottschalk S, Triplett BM, Naik S. Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML. Bone Marrow Transplant Mar 1;58(3):328-331, 2023.

Talleur AC, Qudeimat A, Métais JY, Langfitt D, Mamcarz E, Crawford JC, Huang S, Cheng C, Hurley C, Madden R, Sharma A, Suliman A, Srinivasan A, Velasquez MP, Obeng EA, Willis C, Akel S, Karol SE, Inaba H, Bragg A, Zheng W, Zhou SM, Schell S, Tuggle-Brown M, Cullins D, Patil SL, Li Y, Thomas PG, Zebley C, Youngblood B, Pui CH, Lockey T, Geiger TL, Meagher MM, Triplett BM, Gottschalk S. Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL. Blood Adv Nov 9;6(21):5737-5749, 2022.

Wells JR, Kang G, Suliman AY, Li Y, Akel S, Triplett B, Srinivasan A. Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children. Bone Marrow Transplant Aug 1;57(8):1347-1349, 2022.

Epperly R, Talleur AC, Li Y, Schell S, Tuggle M, Métais JY, Huang S, Pei D, Cheng C, Madden R, Mamcarz E, Naik S, Qudeimat A, Sharma A, Srinivasan A, Suliman A, Gottschalk S, Triplett BM. Sub-myeloablative second transplantations with haploidentical donors and post-transplant cyclophosphamide have limited anti-leukemic effects in pediatric patients. Transplant Cell Ther May 1;28(5):262.e1-262.e10, 2022.

Sharma A, Li Y, Huang S, Talleur AC, Suliman A, Qudeimat A, Srinivasan A, Mamcarz E, Madden R, Cheng C, Gottschalk S, Triplett BM. Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS. Bone Marrow Transplant Aug 1;56(8):1866-1875, 2021.

Kaste S, Suliman AY, Li Y, Keerthi D, Kang G, Triplett B, Srinivasan A. Pre- and post-magnetic resonance imaging of hips and knees for detecting osteonecrosis in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transplant Sept 1;55(9):1837-1839, 2020.

Mamcarz E, Madden R, Qudeimat A, Srinivasan A, Talleur A, Sharma A, Suliman A, Maron G, Sunkara A, Kang G, Leung W, Gottschalk S, Triplett BM. Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution. Bone Marrow Transplant May 1;55(5):929-938, 2020.